Frits van Rhee

26.8k citations
446 papers · 21.3k · 4 hit papers · h-index 75

Impact in

  • Hematology top 0.02%
    • Multiple Myeloma Research and Treatments
    • Hematopoietic Stem Cell Transplantation
  • Oncology top 0.1%
    • Peptidase Inhibition and Analysis
    • Viral-associated cancers and disorders
    • CAR-T cell therapy research

Papers in

    • Multiple Myeloma Research and Treatments 272
    • Hematopoietic Stem Cell Transplantation 44
    • Viral-associated cancers and disorders 60
    • Peptidase Inhibition and Analysis 47
    • Cancer Treatment and Pharmacology 32

Frits van Rhee

433 papers receiving 20.7k citations

Frits van Rhee's Hit Papers

International, evidence-based consensus diagnostic criteria for HHV-8–negative/idiopathic multicentric Castleman disease 2017 · 443 citations
4430+6+13Years since publication250500750

Peers

Frits van Rhee
Comparison fields: 5 of 140
  • Hematology 13.9k
  • Oncology 9.1k
  • Genetics 2.4k
  • Immunology 2.7k
  • Molecular Biology 8.6k
Replace Pellegrino Musto with:
Pellegrino Musto Italy
Jean‐Luc Harousseau France
David Dingli United States
Parameswaran Hari United States
Michel Attal France
Francis K. Buadi United States
Xavier P. Leleu France
Steven Michael Devine United States
Hans Erik Johnsen Denmark
Henry Miles Prince Australia
Frits van Rhee relative to Pellegrino Musto Italy Pellegrino Musto's profile →
Citations per field
00.5×1.5×
Pellegrino Musto · 1×
Citations per year

Countries citing papers authored by Frits van Rhee

Since Specialization
Citations

This map shows the geographic impact of Frits van Rhee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frits van Rhee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frits van Rhee more than expected).

Fields of papers citing papers by Frits van Rhee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frits van Rhee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frits van Rhee. The network helps show where Frits van Rhee may publish in the future.

Co-authors

The 25 scholars most cited alongside Frits van Rhee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Frits van Rhee Line = papers co-authored together Frits van Rhee links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 446 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The molecular classification of multiple myeloma
Hit paper breakdown →
2006927
2
A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1
Hit paper breakdown →
2006764
3
Thalidomide and Hematopoietic-Cell Transplantation for Multiple Myeloma
Hit paper breakdown →
2006614
4 2002545
5 2008475
6
International, evidence-based consensus diagnostic criteria for HHV-8–negative/idiopathic multicentric Castleman disease
Hit paper breakdown →
2017443
7 2009424
8 2006398
9 2014361
10 2017337
11 2006333
12 2007332
13 2012312
14 2011301
15 1994299
16 2018296
17 2007284
18 2014254
19 2000238
20 2016233

About Frits van Rhee

Frits van Rhee is a scholar working on Hematology, Oncology, Genetics, Molecular Biology and Pathology and Forensic Medicine, having authored 446 papers that have together received 21.3k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (272 papers), Protein Degradation and Inhibitors (87 papers), Viral-associated cancers and disorders (60 papers), Peptidase Inhibition and Analysis (47 papers), Hematopoietic Stem Cell Transplantation (44 papers), Lymphoma Diagnosis and Treatment (42 papers), Chronic Lymphocytic Leukemia Research (33 papers) and Cancer Treatment and Pharmacology (32 papers). The work is most often cited by research in Hematology (13.9k citations), Oncology (9.1k citations), Genetics (2.4k citations), Immunology (2.7k citations) and Molecular Biology (8.6k citations). Frits van Rhee has collaborated with scholars based in United States, United Kingdom and Jordan. Frequent co-authors include Bart Barlogie, John D. Shaughnessy, John Crowley, Maurizio Zangari, Guido J. K. Tricot, Elias J. Anaissie, Joshua Epstein, Mauricio Pineda‐Roman, Klaus A. Hollmig and Antje Hoering. Their work appears in journals such as Blood, British Journal of Haematology, Bone Marrow Transplantation, American Journal of Hematology and Blood Advances.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact